Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000152

EVP, Chf Clinical Develop Ofcr sold 5,812 shares at $70.97 ($412,486)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Schneider Eugene EVP, Chf Clinical Develop Ofcr 2026-03-19 Sale 10b5-1 −5,812 $70.97 $412,486 63,890 D: show line 1 in the form
Open-market sales · 5,812 sh · avg $70.97 · $412,486
Loading xslF345X06/primary_doc.xml…